Early adoption of pharmacogenetic testing for veterans prescribed psychotropic medications

N/ACitations
Citations of this article
20Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Aim: Describe the characteristics of providers ordering, patients receiving, and clinical impact of a psychotropic pharmacogenetic test on veteran care. Patients & methods: Observational cohort study linking veterans' laboratory results to electronic health record data. Changes in psychotropic medication prescribing were measured as a function of test results. Results: A total of 38 providers tested 181 veterans between 10/6/2014 and 2/1/2018. Prescriptions for medications with severe gene-drug interactions decreased; however, 11 such medications were used after testing. For 43 patients, documentation of the results was missing. Conclusion: Most prescribing decisions were congruent with test results, but in a nontrivial number of cases, prescribers appeared not to act on the results. Poor result documentation impeded the potential of results to inform clinical care.

Cite

CITATION STYLE

APA

Hull, L. E., Chanfreau-Coffinier, C., Tuteja, S., Berlowitz, D., Lehmann, L. S., Oslin, D. W., … Lynch, J. A. (2019). Early adoption of pharmacogenetic testing for veterans prescribed psychotropic medications. Pharmacogenomics, 20(11), 781–789. https://doi.org/10.2217/pgs-2019-0065

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free